CONTEXT: Recently, 10 novel type 2 diabetes (T2D) susceptibility single nucleotide polymorphisms (SNPs) in ZMIZ1, ANK1, KLHDC5, TLE1, ANKRD55, CILP2, MC4R, BCAR1, HMG20A, and GRB14 loci were discovered in MetaboChip-genotyped populations of European ancestry. OBJECTIVE: The aim of the present study was to characterize prediabetic quantitative traits underlying these SNP associations and to calculate the amount of interindividual variation in glycemic traits explained by these and previous T2D susceptibility variants. DESIGN AND PARTICIPANTS: A total of 5739 Danish individuals naive to glucose-lowering medication were included in quantitative trait studies, and case-control analyses were performed in 1892 patients with T2D and 6603 normoglycemic control subjects. Participants without known T2D underwent an oral glucose tolerance test, and measures of insulin release and sensitivity were estimated from insulinogenic, disposition, BIGTT, and Matsuda indexes. RESULTS: We confirmed associations of ZMIZ1, KLHDC5, CILP2, HMG20A, ANK1, ANKRD55, and BCAR1 with T2D. The risk T allele of BCAR1 rs7202877 associated with decreased disposition index (P = .02). The C allele of ANK1 rs516946 associated with decreased insulinogenic (P = .005) and disposition (P = .002) indexes. The G allele of ANKRD55 rs459193 associated with decreased Matsuda index (P = .02) adjusted for waist circumference. The C allele of GRB14 rs13389219 associated with both increased insulinogenic (P = .04) and decreased Matsuda (P = .05) indexes. All validated European T2D variants still only explained a few percentage points of glycemic trait variation. CONCLUSIONS: BCAR1 rs7202877 may mediate its diabetogenic impact through impaired β-cell function, but this finding needs to be replicated in independent studies. In addition, we substantiated previous evidence that ANK1 rs516946 confers impaired insulin release and that ANKRD55 rs459193 and GRB14 rs13389219 associate with insulin resistance.
CONTEXT: Recently, 10 novel type 2 diabetes (T2D) susceptibility single nucleotide polymorphisms (SNPs) in ZMIZ1, ANK1, KLHDC5, TLE1, ANKRD55, CILP2, MC4R, BCAR1, HMG20A, and GRB14 loci were discovered in MetaboChip-genotyped populations of European ancestry. OBJECTIVE: The aim of the present study was to characterize prediabetic quantitative traits underlying these SNP associations and to calculate the amount of interindividual variation in glycemic traits explained by these and previous T2D susceptibility variants. DESIGN AND PARTICIPANTS: A total of 5739 Danish individuals naive to glucose-lowering medication were included in quantitative trait studies, and case-control analyses were performed in 1892 patients with T2D and 6603 normoglycemic control subjects. Participants without known T2D underwent an oral glucose tolerance test, and measures of insulin release and sensitivity were estimated from insulinogenic, disposition, BIGTT, and Matsuda indexes. RESULTS: We confirmed associations of ZMIZ1, KLHDC5, CILP2, HMG20A, ANK1, ANKRD55, and BCAR1 with T2D. The risk T allele of BCAR1rs7202877 associated with decreased disposition index (P = .02). The C allele of ANK1rs516946 associated with decreased insulinogenic (P = .005) and disposition (P = .002) indexes. The G allele of ANKRD55rs459193 associated with decreased Matsuda index (P = .02) adjusted for waist circumference. The C allele of GRB14rs13389219 associated with both increased insulinogenic (P = .04) and decreased Matsuda (P = .05) indexes. All validated European T2D variants still only explained a few percentage points of glycemic trait variation. CONCLUSIONS:BCAR1rs7202877 may mediate its diabetogenic impact through impaired β-cell function, but this finding needs to be replicated in independent studies. In addition, we substantiated previous evidence that ANK1rs516946 confers impaired insulin release and that ANKRD55rs459193 and GRB14rs13389219 associate with insulin resistance.
Authors: Christopher A Lowry; David G Smith; Philip H Siebler; Dominic Schmidt; Christopher E Stamper; James E Hassell; Paula S Yamashita; James H Fox; Stefan O Reber; Lisa A Brenner; Andrew J Hoisington; Teodor T Postolache; Kerry A Kinney; Dante Marciani; Mark Hernandez; Sian M J Hemmings; Stefanie Malan-Muller; Kenneth P Wright; Rob Knight; Charles L Raison; Graham A W Rook Journal: Curr Environ Health Rep Date: 2016-09
Authors: Sian M J Hemmings; Stefanie Malan-Müller; Leigh L van den Heuvel; Brittany A Demmitt; Maggie A Stanislawski; David G Smith; Adam D Bohr; Christopher E Stamper; Embriette R Hyde; James T Morton; Clarisse A Marotz; Philip H Siebler; Maarten Braspenning; Wim Van Criekinge; Andrew J Hoisington; Lisa A Brenner; Teodor T Postolache; Matthew B McQueen; Kenneth S Krauter; Rob Knight; Soraya Seedat; Christopher A Lowry Journal: Psychosom Med Date: 2017-10 Impact factor: 4.312
Authors: Murray B Stein; Chia-Yen Chen; Robert J Ursano; Tianxi Cai; Joel Gelernter; Steven G Heeringa; Sonia Jain; Kevin P Jensen; Adam X Maihofer; Colter Mitchell; Caroline M Nievergelt; Matthew K Nock; Benjamin M Neale; Renato Polimanti; Stephan Ripke; Xiaoying Sun; Michael L Thomas; Qian Wang; Erin B Ware; Susan Borja; Ronald C Kessler; Jordan W Smoller Journal: JAMA Psychiatry Date: 2016-07-01 Impact factor: 21.596
Authors: Kexin Li; Tianyu Feng; Lijuan Wang; Yang Chen; Pingping Zheng; Pan Pan; Min Wang; Isaac T S Binnay; Yingshuang Wang; Ruiyu Chai; Siyu Liu; Bo Li; Yan Yao Journal: Mol Genet Genomics Date: 2021-02-25 Impact factor: 3.291